243 related articles for article (PubMed ID: 21330966)
1. Potential transmission of viral hepatitis through use of stored blood vessels as conduits in organ transplantation--Pennsylvania, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Feb; 60(6):172-4. PubMed ID: 21330966
[TBL] [Abstract][Full Text] [Related]
2. Potential transmission of viral hepatitis through use of stored blood vessels as conduits in Organ Transplantation-Pennsylvania, 2009.
Centers for Disease Control and Prevention (CDC)
Am J Transplant; 2011 Apr; 11(4):863-5. PubMed ID: 21446983
[No Abstract] [Full Text] [Related]
3. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
[TBL] [Abstract][Full Text] [Related]
4. Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation.
Ahn J; Cohen SM
Liver Transpl; 2008 Nov; 14(11):1603-8. PubMed ID: 18975294
[TBL] [Abstract][Full Text] [Related]
5. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
6. Donor screening for hepatitis B virus infection in a cell and tissue bank.
Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
Zekri AR; Mohamed WS; Samra MA; Sherif GM; El-Shehaby AM; El-Sayed MH
Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744
[TBL] [Abstract][Full Text] [Related]
8. Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage.
Fabrizio F; Bunnapradist S; Martin P
J Nephrol; 2002; 15(6):605-13. PubMed ID: 12495272
[TBL] [Abstract][Full Text] [Related]
9. Role of nucleic acid testing in cadaver organ donor screening: detection of hepatitis C virus RNA in seropositive and seronegative donors.
Aswad S; Khan NS; Comanor L; Chinchilla C; Corado L; Mone T; Mendez R; Mendez R
J Viral Hepat; 2005 Nov; 12(6):627-34. PubMed ID: 16255764
[TBL] [Abstract][Full Text] [Related]
10. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.
Wachs ME; Amend WJ; Ascher NL; Bretan PN; Emond J; Lake JR; Melzer JS; Roberts JP; Tomlanovich SJ; Vincenti F
Transplantation; 1995 Jan; 59(2):230-4. PubMed ID: 7839446
[TBL] [Abstract][Full Text] [Related]
11. Risk of transmission of hepatitis B virus from anti-HBC positive cadaveric organ donors: a collaborative study.
De Feo TM; Poli F; Mozzi F; Moretti MP; Scalamogna M;
Transplant Proc; 2005 Mar; 37(2):1238-9. PubMed ID: 15848681
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors.
Challine D; Chevaliez S; Pawlotsky JM
Gastroenterology; 2008 Oct; 135(4):1185-91. PubMed ID: 18694749
[TBL] [Abstract][Full Text] [Related]
13. Kidney transplantation from donors with viral B and C hepatitis.
Veroux P; Veroux M; Sparacino V; Giuffrida G; Puliatti C; Macarone M; Fiamingo P; Cappello D; Gagliano M; Spataro M; Di Mare M; Cannizzaro MA; Severino V
Transplant Proc; 2006 May; 38(4):996-8. PubMed ID: 16757242
[TBL] [Abstract][Full Text] [Related]
14. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
15. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
[TBL] [Abstract][Full Text] [Related]
16. Detection of hepatitis C virus infection among cadaver organ donors: evidence for low transmission of disease.
Roth D; Fernandez JA; Babischkin S; De Mattos A; Buck BE; Quan S; Olson L; Burke GW; Nery JR; Esquenazi V
Ann Intern Med; 1992 Sep; 117(6):470-5. PubMed ID: 1323944
[TBL] [Abstract][Full Text] [Related]
17. Transmission of hepatitis C virus through transplanted organs and tissue--Kentucky and Massachusetts, 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(50):1697-700. PubMed ID: 22189891
[TBL] [Abstract][Full Text] [Related]
18. Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression.
Toniutto P; Minisini R; Fabris C; De Feo T; Marangoni F; Burlone M; Avellini C; Bitetto D; Fornasiere E; Fumolo E; Baccarani U; Pirisi M
Clin Transplant; 2009; 23(2):184-90. PubMed ID: 19210526
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B and C serologic profiles of Canadian organ donors and recipients: retrospective 10-year review at a single center.
Burton CE; Doucette KE; Mabilangan CA; Plitt SS; Lee BE; Preiksaitis JK
Transpl Infect Dis; 2016 Aug; 18(4):520-8. PubMed ID: 27226204
[TBL] [Abstract][Full Text] [Related]
20. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States.
Zou S; Dodd RY; Stramer SL; Strong DM;
N Engl J Med; 2004 Aug; 351(8):751-9. PubMed ID: 15317888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
